Agios Pharmaceuticals Inc. is learning the hard way the downside of having a pipeline in a product. When a side effect crops up, investors are likely to worry that it may affect the potential of the ...
The Biosecure Act missed its expected ride through the U.S. Congress via the National Defense Authorization Act, but it may not be the end of the road for the bill that would prohibit direct or ...
Although it does not generally infect humans, a single mutation of the H5N1 virus in the highly pathogenic avian and bovine clade 2.3.4.4b could overcome this barrier and possibly trigger a pandemic.
In a recently published study, researchers from Taipei Medical University and collaborators have reported on their efforts to discover new DYRK1A-specific inhibitors.
North Health Ltd. raised $6 million in financing to bring its oncology products to the market including the Neutrocheck, a ...
A ketone body, a molecule derived from the metabolism of acids to obtain energy when glucose is not available, could become ...
Methods that may work well for recruiting and retaining white patients for clinical trials may need to be adjusted to ...
Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...
Neo Medical SA received certification under the EU Medical Device Regulation for its entire portfolio of spine surgical ...
A federal jury awarded Insulet Corp. $452 million against Eoflow Co. Ltd., concluding that Eoflow and other defendants stole ...
Sunshine Biopharma Inc. has completed mouse model studies providing proof of concept for the company’s K1.1 mRNA product as a ...
Spur Therapeutics Ltd. has selected SPR-301 as lead development candidate from its gene therapy program for a genetically ...